Oncology

Latest News

The new report suggests the C5a-C5aRq axis might be a useful target in combination with existing therapies for cutaneous squamous cell carcinoma. | Image credit: vladimircaribb - stock.adobe.com
C5aR1 Flagged as Biomarker in Cutaneous Squamous Cell Carcinoma

June 7th 2025

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

The study identified several molecular markers related to SCLC prognosis by integrating somatic mutation profiles, mRNA transcriptome data, and clinical information. | Image credit: vitstudio - stock.adobe.com
Novel Biomarkers May Inform Prognosis in SCLC

June 6th 2025

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, authors of the COMMANDS study recommended. | Image credit: Drazen - stock.adobe.com
Structured Exercise Program Improves Outcomes, Quality of Life in Colon Cancer

June 6th 2025

young adult cancer | Image credit: Roswell Park Cancer Center
ASCO Sessions Explore Data and Dynamics of Early-Onset Cancer

June 6th 2025

FDA headquarters | Image Credit: - Tada Images- stock.adobe.com
5 Key FDA Approval Dates Mark a Milestone-Filled May

June 6th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

The Future of Value-Based Care and Payment Models in Cancer Care
November 24th 2016

The Future of Value-Based Care and Payment Models in Cancer Care

Do APMs Incorporate Survivorship Care in Oncology?
November 24th 2016

Do APMs Incorporate Survivorship Care in Oncology?

Patient Centricity of Care Delivery and Payment Models
November 24th 2016

Patient Centricity of Care Delivery and Payment Models

The Balancing Act of Healthcare Costs
November 24th 2016

The Balancing Act of Healthcare Costs

Innovative Technology and Healthcare Costs
November 24th 2016

Innovative Technology and Healthcare Costs

Importance of Data Sharing in Healthcare
November 24th 2016

Importance of Data Sharing in Healthcare

Leveraging Health IT in Cancer Care
November 24th 2016

Leveraging Health IT in Cancer Care

Who Shares the Maximum Risk With Innovative Treatments in Oncology?
November 24th 2016

Who Shares the Maximum Risk With Innovative Treatments in Oncology?

Site of Service and the Challenge of Value-Based Care
November 24th 2016

Site of Service and the Challenge of Value-Based Care

Risk-Based Contracting in Oncology
November 24th 2016

Risk-Based Contracting in Oncology

Benefits of a Medical Home Model in Oncology
November 24th 2016

Benefits of a Medical Home Model in Oncology

Population Health and APMs
November 24th 2016

Population Health and APMs

Is the Oncology Care Model Patient Centered?
November 24th 2016

Is the Oncology Care Model Patient Centered?

Value-Based Care and APMs in Oncology: A Payer Perspective
November 24th 2016

Value-Based Care and APMs in Oncology: A Payer Perspective

Adapting and Paying for Value-Based Care
November 24th 2016

Adapting and Paying for Value-Based Care

Defining Alternative Payment Models
November 24th 2016

Defining Alternative Payment Models

Site Logo
November 23rd 2016

Another Death Reported in Juno's CAR-T Trial in Patients With ALL

AJMC Staff
Within 4 months of the last reported incident, Juno Therapeutics has again halted the phase 2 “Rocket” trial of JCAR015 in patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).
Site Logo
November 23rd 2016

5 Key Highlights From the Patient-Centered Oncology Care Meeting

Surabhi Dangi-Garimella, PhD
Here's a glimpse into what The American Journal of Managed Care’s 5th annual Patient-Centered Oncology Care® meeting had in store for its attendees.
Dr Robert Carlson Predicts 2017 Will Be "Year of Uncertainty" For Healthcare
November 23rd 2016

Dr Robert Carlson Predicts 2017 Will Be "Year of Uncertainty" For Healthcare

There is significant uncertainty surrounding the healthcare system’s future in 2017 under a Republican Congress and President, but it’s unlikely that the Affordable Care Act will be repealed without some replacement that accommodates the individuals newly covered by it, said Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network.
PCOC16: Panel Discussion on the Future of Oncology Care
November 23rd 2016

PCOC16: Panel Discussion on the Future of Oncology Care

The 5th Annual Patient-Centered Oncology Care Meeting closed out with a panel discussion with an eye on the future. Donald Trump's surprise election has caused turmoil in the healthcare industry as the Affordable Care Act seems certain to be repealed at least in part. However, the move to value-based care will likely continue as planned.
This Week in Managed Care: November 23, 2016
November 23rd 2016

This Week in Managed Care: November 23, 2016

This week, the top managed care stories included the FDA's approval of rival combination therapies for type 2 diabetes, the American Medical Association issued mHealth guidelines, and a study found the dementia rate declining.
Debra Madden: Oncologists Should Anticipate Patient Concerns About Immunotherapy
November 23rd 2016

Debra Madden: Oncologists Should Anticipate Patient Concerns About Immunotherapy

When helping cancer patients decide if immuno-oncology treatments are right for them, clinicians should not focus only on the potential risks and benefits, said Debra L. Madden, cancer research advocate and patient representative. Oncologists should ensure patients are aware of the variable responses to the therapy, like the phenomenon of pseudoprogression.
Site Logo
November 23rd 2016

PCOC16: Integrating Patient-Centered Outcomes in APMs

Surabhi Dangi-Garimella, PhD
At the 5th annual Patient-Centered Oncology Care® meeting in Baltimore, Maryland, moderator Bruce Feinberg, DO, was joined by a care provider, a payer, and a community oncology representative to discuss efforts that maintain the patient at the core of payment models.
Site Logo
November 23rd 2016

Lung Cancer Screening Reveals How Deadly Smoking Is for Those With Diabetes

Mary Caffrey
While smoking has long been known to aggravate diabetes, the new study shows just how deadly the habit is for those with the chronic condition.
Site Logo
November 22nd 2016

PCOC16: "Oncology Care 2017" Panel Discusses Future of Cancer Care

Christina Mattina
The 5th annual Patient-Centered Oncology Care® (PCOC) meeting, hosted by The American Journal of Managed Care, November 17-18, in Baltimore, Maryland, concluded with a panel discussion on the future of oncology care in 2017. The panelists concurred that value-based payment is here to stay despite the imminent changes in healthcare.
Site Logo
November 22nd 2016

PCOC16: Unraveling the Value in Oncology Care for the Payer

Surabhi Dangi-Garimella, PhD
At the 5th annual Patient-Centered Oncology Care® meeting, Roy Beveridge, MD, senior vice president and chief medical officer at Humana, walked the audience through the healthcare world’s transition to value-based care and explained why payers have faith in this transition.
Site Logo
November 22nd 2016

Do We Need to Realign Evidence-Based Versus Precision Medicine?

Debra Madden
An interview with geneticist and pathologist Gabriel Bien-Willner, MD, PhD, FCAP, on why we need to change our outlook toward precision medicine in oncology.
Dr Roy Beveridge: Value-Based Care Brings Caregivers Together
November 21st 2016

Dr Roy Beveridge: Value-Based Care Brings Caregivers Together

Value-based care in oncology will be a great thing for patients because it will bring the caregivers together, said Roy Beveridge, MD, chief medical officer of Humana and the keynote speaker at Patient-Centered Oncology Care.
Site Logo
November 21st 2016

Catching Them Early: Outreach Program Could Avert HCC in Cirrhosis Patients

Surabhi Dangi-Garimella, PhD
A prospective trial that reached out to patients with cirrhosis to undergo an ultrasound screen found that the outreach effort doubled the percentage of patients who were screened for hepatocellular carcinoma.
Site Logo
November 21st 2016

Little Patient Benefit to Using G-CSF to Prevent Neutropenia

Laura Joszt, MA
There is little patient benefit to using granulocyte colony-stimulating factor (G-CSF) to help white blood cell growth and reduce the risk of infection in women with breast cancer, according to a study published in Journal of Clinical Oncology.
<1
...
878889909192939495
...
185>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo